A 33 years old patient with history of asthma is being treated for symptoms of hypertension. Which of the following beta blocker would be an appropriate therapy for this patient:
First, I remember that beta-blockers are generally contraindicated in asthma because they can cause bronchoconstriction. But there are exceptions. Some beta-blockers are cardioselective, meaning they mainly affect beta-1 receptors in the heart, not beta-2 in the lungs. So, maybe the correct answer is a cardioselective one.
Wait, the options aren't listed here, but common beta-blockers include propranolol (non-selective), metoprolol (beta-1 selective), atenolol (also beta-1), and maybe carvedilol (non-selective with alpha activity). So for asthma patients, the cardioselective ones like metoprolol or atenolol would be safer because they don't block beta-2 receptors as much, reducing the risk of bronchoconstriction.
The wrong options would be non-selective beta-blockers like propranolol, which block both beta-1 and beta-2, leading to potential worsening of asthma. Carvedilol is also non-selective and has alpha-blocking properties, which might not be ideal here. Labetalol is another one that's non-selective. So the correct answer would be a beta-1 selective blocker.
Clinical pearl: Always avoid non-selective beta-blockers in patients with asthma. Use cardioselective ones instead. So if the options include metoprolol, that's the answer.
**Core Concept**
Beta-blockers with cardioselectivity (beta-1 receptor specificity) are preferred in asthmatic patients with hypertension to avoid bronchoconstriction caused by beta-2 receptor blockade. Non-selective beta-blockers exacerbate asthma by inhibiting bronchodilation via beta-2 receptors in the lungs.
**Why the Correct Answer is Right**
Cardioselective beta-blockers like **metoprolol** or **atenolol** selectively inhibit beta-1 receptors in the heart, reducing cardiac output and blood pressure without significantly affecting beta-2 receptors in bronchial smooth muscle. This minimizes the risk of airway narrowing, making them safer than non-selective agents in patients with asthma.
**Why Each Wrong Option is Incorrect**
**Option A:** *Propranolol* (non-selective) blocks both beta-1 and beta-2 receptors, causing bronchoconstriction and worsening asthma.
**Option B:** *Carvedilol* (non-selective with alpha-1 blockade) also blocks beta-2 receptors, increasing asthma risk.
**Option C:** *Labetalol* (combined alpha/beta-blocker) is non-selective for beta-receptors, leading to similar bronchoconstrictive risks.
**Clinical Pearl / High-Yield Fact**
**Avoid non-selective beta-blockers in asthma.** Use cardioselective agents like metoprolol or bisoprolol. Remember: **"Beta-1 for the heart, not Beta-2 for the lungs!"** Non-selective agents (e.g., propranolol) are red flags for asthma patients.
**Correct Answer: B. Metoprolol**